Pedro Castelo‐Branco
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Aging top 10%
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 12
- RNA Interference and Gene Delivery 3
- Oncology top 10%
- Cancer Cells and Metastasis 5
-
- Lung Cancer Treatments and Mutations 7
- Gastric Cancer Management and Outcomes 5
-
- Virus-based gene therapy research 4
-
- Telomeres, Telomerase, and Senescence 4
Pedro Castelo‐Branco
42 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 105
- Cancer Research 248
- Aging 24
- Molecular Biology 853
- Oncology 329
- Immunology 161
Countries citing papers authored by Pedro Castelo‐Branco
This map shows the geographic impact of Pedro Castelo‐Branco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Castelo‐Branco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Castelo‐Branco more than expected).
Fields of papers citing papers by Pedro Castelo‐Branco
This network shows the impact of papers produced by Pedro Castelo‐Branco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Castelo‐Branco. The network helps show where Pedro Castelo‐Branco may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pedro Castelo‐Branco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 14 | |
| 6 | 2022 | 13 | |
| 7 | 2022 | 9 | |
| 8 | 2021 | 18 | |
| 9 | 2021 | 4 | |
| 10 | 2019 | 98 | |
| 11 | 2018 | 195 | |
| 12 | 2018 | 22 | |
| 13 | 2017 | 63 | |
| 14 | 2016 | 3 | |
| 15 | 2011 | 35 | |
| 16 | 2011 | 42 | |
| 17 | 2010 | 27 | |
| 18 | 2009 | 32 | |
| 19 | 2008 | 66 | |
| 20 | 2004 | 138 |
About Pedro Castelo‐Branco
Pedro Castelo‐Branco is a scholar working on Equine, Aging and Oncology, having authored 47 papers that have together received 1.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (12 papers), Lung Cancer Treatments and Mutations (7 papers), Cancer Cells and Metastasis (5 papers), Gastric Cancer Management and Outcomes (5 papers), Virus-based gene therapy research (4 papers), MicroRNA in disease regulation (4 papers), Telomeres, Telomerase, and Senescence (4 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Cancer Research (248 citations), Aging (24 citations) and Molecular Biology (853 citations). Pedro Castelo‐Branco has collaborated with scholars based in Portugal, Canada and Brazil. Frequent co-authors include Joana Apolónio, Ricardo Leão, Uri Tabori, Alexandra Binnie, Arnaldo Figueiredo, Ramon Andrade de Mello, Dong‐Hyun Lee, Samuel D. Rabkin, Célia Domingos and Nicholas Proudfoot. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.